Methanesulfonamide structure
|
Common Name | Methanesulfonamide | ||
---|---|---|---|---|
CAS Number | 3144-09-0 | Molecular Weight | 95.12 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 208.2±23.0 °C at 760 mmHg | |
Molecular Formula | CH5NO2S | Melting Point | 85-89 °C(lit.) | |
MSDS | USA | Flash Point | 79.7±22.6 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of MethanesulfonamideMethanesulfonamide is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
Name | Methanesulfonamide |
---|---|
Synonym | More Synonyms |
Description | Methanesulfonamide is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
---|---|
Related Catalog | |
In Vitro | 甲磺酰胺与亚硫酰氯、氰酸盐、二硫化碳及酮、醛反应制备药物、光亮剂等目标分子。它还用于生物学研究,以预测蛋白质配体复合物的结合亲和力和结合模式。 |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 208.2±23.0 °C at 760 mmHg |
Melting Point | 85-89 °C(lit.) |
Molecular Formula | CH5NO2S |
Molecular Weight | 95.12 |
Flash Point | 79.7±22.6 °C |
Exact Mass | 95.004097 |
PSA | 68.54000 |
LogP | -1.29 |
Vapour Pressure | 0.2±0.4 mmHg at 25°C |
Index of Refraction | 1.460 |
Storage condition | 2~8℃ |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi:Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36-S24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 29350090 |
Precursor 8 | |
---|---|
DownStream 10 | |
HS Code | 2935009090 |
---|---|
Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |
Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner.
Arthritis. Res. Ther. 17 , 321, (2015) The endocannabinoid system modulates function of immune cells and mesenchymal cells such as fibroblasts, which contribute to cartilage destruction in rheumatoid arthritis (RA). The aim of the study wa... |
|
Inhibition of cyclooxygenase-2 causes a decrease in coronary flow in diabetic mice. The possible role of PGE2 and dysfunctional vasodilation mediated by prostacyclin receptor.
J. Physiol. Biochem. 71 , 351-8, (2015) Several lines of evidence suggest that cyclooxygenase-2 (COX-2) activity can have a beneficial role in the maintenance of vascular tone of the blood vessels in diabetes. Specifically, the increased pr... |
|
In vitro antitumor mechanism of (E)-N-(2-methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)pyridin-3-yl)methanesulfonamide.
Mol. Pharmacol. 87(1) , 18-30, (2015) ON01910.Na [sodium (E)-2-(2-methoxy-5-((2,4,6-trimethoxystyrylsulfonyl)methyl)phenylamino)acetate; Rigosertib, Estybon], a styryl benzylsulfone, is a phase III stage anticancer agent. This non-ATP com... |
MFCD00007940 |
aminosulfane dioxide |
Methanesulfonamide |
Methylsulfonamide |
methansulfonamid |
methanesulfonyl amine |
Methane sulfonamide |
EINECS 221-553-6 |
methylsulfonylamine |
Methanesulphonamide |